The results indicated that unlike sunitinib, another commonly used anti-angiogenic agent in the clinics which targets vascular endothelial growth factor – A (VEGFA) receptors, dopamine (DA) not only could inhibit tumor angiogenesis and growth of HT29 human colon cancer and LLC (Lewis lung carcinoma).

READ FULL ARTICLE Curated publisher From Mdlinx